Literature DB >> 11766099

Phospholipases of Candida albicans.

M Niewerth1, H C Korting.   

Abstract

Infections due to Candida albicans are frequent and of clinical importance. Especially at a time of increasing organ transplantations, HIV infections, and resistance to antimicrobial agents a profound knowledge of the interaction between C. albicans and host tissue is mandatory. In addition to secreted aspartyl proteinase, dimorphism, cell surface composition, and toxin production phospholipases are a main factor in pathogenicity. Up to the present, many different groups and subgroups of phospholipases have been detected. These different enzymes are related to various types of aggressive and defensive actions. These range from active invasion of host cell tissue to growth control and remodelling of the yeast cell membrane. It is clear that a multiplicity of factors must co-operate to overcome the host's defences. Yet it can be supposed today that phospholipases are one important factor in this complex interaction. Therefore the known phospholipases of C. albicans are described in detail under clinical aspects.

Entities:  

Mesh:

Year:  2001        PMID: 11766099     DOI: 10.1046/j.1439-0507.2001.00685.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  16 in total

Review 1.  Interaction of Candida albicans with host cells: virulence factors, host defense, escape strategies, and the microbiota.

Authors:  Sarah Höfs; Selene Mogavero; Bernhard Hube
Journal:  J Microbiol       Date:  2016-02-27       Impact factor: 3.422

2.  Necrotizing fasciitis following a motor vehicle accident with Candida species as the sole organisms.

Authors:  Daniel Brian Eisen; Erin Brown
Journal:  Can J Plast Surg       Date:  2004

3.  Mechanism underlying renal failure caused by pathogenic Candida albicans infection.

Authors:  Shin Jae-Chen; Jeon Young-Joo; Park Seon-Min; Seo Kang Seok; Shim Jung-Hyun; Chae Jung-Il
Journal:  Biomed Rep       Date:  2014-11-24

4.  Inhibition of Phospholipase by Orlistat as an Alternate Therapy to Combat Opportunistic Mycosis Caused by C. albicans.

Authors:  Hardi Sinde; Priyanka Patel; Kunjan M Kikani; Dhyey R Kothari; Bhavtosh A Kikani
Journal:  Curr Microbiol       Date:  2021-04-03       Impact factor: 2.188

5.  Candida albicans and Candida tropicalis in oral candidosis: quantitative analysis, exoenzyme activity, and antifungal drug sensitivity.

Authors:  Karen Regina Carim da Costa; Joseane Cristina Ferreira; Marilena Chinali Komesu; Regina Celia Candido
Journal:  Mycopathologia       Date:  2008-09-12       Impact factor: 2.574

6.  Virulence factors of fluconazole-susceptible and fluconazole-resistant Candida albicans after antimicrobial photodynamic therapy.

Authors:  Fernanda Alves; Ewerton Garcia de Oliveira Mima; Renata Caroline Polato Passador; Vanderlei Salvador Bagnato; Janaína Habib Jorge; Ana Cláudia Pavarina
Journal:  Lasers Med Sci       Date:  2017-03-09       Impact factor: 3.161

Review 7.  Environmental sensing and signal transduction pathways regulating morphopathogenic determinants of Candida albicans.

Authors:  Subhrajit Biswas; Patrick Van Dijck; Asis Datta
Journal:  Microbiol Mol Biol Rev       Date:  2007-06       Impact factor: 11.056

8.  Candida albicans versus Candida dubliniensis: Why Is C. albicans More Pathogenic?

Authors:  Gary P Moran; David C Coleman; Derek J Sullivan
Journal:  Int J Microbiol       Date:  2011-09-04

Review 9.  Dissecting Candida albicans Infection from the Perspective of C. albicans Virulence and Omics Approaches on Host-Pathogen Interaction: A Review.

Authors:  Voon Kin Chin; Tze Yan Lee; Basir Rusliza; Pei Pei Chong
Journal:  Int J Mol Sci       Date:  2016-10-18       Impact factor: 5.923

Review 10.  Candida albicans pathogenicity mechanisms.

Authors:  François L Mayer; Duncan Wilson; Bernhard Hube
Journal:  Virulence       Date:  2013-01-09       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.